Effects of dietary supplement containing ceramide on dry skin: a randomized, double blind, placebo-controlled study

Effects of dietary supplement containing ceramide on dry skin: a randomized, double blind, placebo-controlled study - Effects of dietary supplement containing ceramide on dry skin: a randomized, double blind, placebo-controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016031

Enrollment

Registered

2015-01-10

Start date

2015-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry skin

Interventions

Duration: 8 weeks Test material: supplement containing ceramide(Tablets) 3 tablets one times per day after dinner Duration: 8 weeks Test material: plasebo(Tablet) 3 tablets one times per day af

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women over 40 years old that there is awareness of rough skin due to drying

Exclusion criteria

Exclusion criteria: -Patients with atopic dermatitis -Under treatment of steroid or anti-allergic agents(including OTC drug). -Patients Moderate or more of allergic rhinitis. -Subjects who have a history of serious disorder. -Subject who are under treatment or supervised by physician. -At the time of the study start persons participating in other clinical trials. -Subjects who are difficult to maintain the lifestyle (diet, sleep, skin care, etc.) -Subjects who are difficult to keep a daily record of symptoms. -Subjects who are pregnant or under lactation. -Subjects who are judged ineligible by our physician.

Design outcomes

Primary

Measure	Time frame
Moisture content of the stratum corneum	—

Countries

Japan

Contacts

Public ContactIsako Horiguchi

EBC&M LLC Project planning &Development department

info@ebc-m.com03-6465-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026